Update on the Diagnosis and Management of Familial Long QT Syndrome

Heart Lung and Circulation

Volumn 25, Issue 8, 2016, Pages 769-776

  Waddell Smith, Kathryn E ^a,b   Skinner, Jonathan R ^a,b  

^a STARSHIP CHILDREN S HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Diagnosis; Genetics; Long QT syndrome; Management; Sudden death

Indexed keywords

NADOLOL; POTASSIUM CHANNEL KCNQ1; SODIUM CHANNEL NAV1.5; KCNH2 PROTEIN, HUMAN; KCNQ1 PROTEIN, HUMAN; NOS1AP PROTEIN, HUMAN; POTASSIUM CHANNEL HERG; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

CARDIOVASCULAR RISK; CLINICAL FEATURE; ELECTROCARDIOGRAPHY; FAMILY HISTORY; GENE; GENE REARRANGEMENT; GENETIC COUNSELING; GENETIC SCREENING; HEART DENERVATION; HIGH RISK POPULATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; KCNH2 GENE; KCNQ1 GENE; LEFT CARDIAC SYMPATHETIC DENERVATION; LETTER; LIFESTYLE MODIFICATION; LONG QT SYNDROME; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; NOS1AP GENE; PATIENT COUNSELING; PRIORITY JOURNAL; RESIDUE ANALYSIS; RISK ASSESSMENT; SCN5A GENE; SCREENING TEST; SUDDEN CARDIAC DEATH; SYMPATHECTOMY; TREATMENT INDICATION; FEMALE; GENETIC DISEASES, INBORN; GENETIC POLYMORPHISM; GENETICS; MALE; MUTATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ERG1 POTASSIUM CHANNEL; FEMALE; GENETIC DISEASES, INBORN; HUMANS; KCNQ1 POTASSIUM CHANNEL; LONG QT SYNDROME; MALE; MUTATION; POLYMORPHISM, GENETIC;

EID: 84973880496     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2016.01.020     Document Type: Letter

References (66)

1. [1] Schwartz, P.J., Stramba-Badiale, M., Crotti, L., Pedrazzini, M., Besana, A., Bosi, G., et al. Prevalence of the congenital long-QT syndrome. Circulation. 120 (2009), 1761–1767.
2. [2] Schwartz, P.J., Moss, A.J., Vincent, G.M., Crampton, R.S., Diagnostic criteria for the long QT syndrome. An update. Circulation. 88 (1993), 782–784.
3. [3] Schwartz, P.J., Crotti, L., QTc behavior during exercise and genetic testing for the long-QT syndrome. Circulation. 124 (2011), 2181–2184.
4. [4] MacCormick, J.M., Crawford, J.R., Chung, S.K., Shelling, A.N., Evans, C.A., Rees, M.I., et al. Symptoms and signs associated with syncope in young people with primary cardiac arrhythmias. Heart Lung Circ. 20 (2011), 593–598.
5. [5] MacCormick, J.M., McAlister, H., Crawford, J., French, J.K., Crozier, I., Shelling, A.N., et al. Misdiagnosis of long QT syndrome as epilepsy at first presentation. Ann Emerg Med. 54 (2009), 26–32.
6. [6] Colman, N., Bakker, A., Linzer, M., Reitsma, J.B., Wieling, W., Wilde, A.A., Value of history-taking in syncope patients: in whom to suspect long QT syndrome?. Europace. 11 (2009), 937–943.
7. [7] Schwartz, P.J., Priori, S.G., Spazzolini, C., Moss, A.J., Vincent, G.M., Napolitano, C., et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 103 (2001), 89–95.
8. [8] Priori, S.G., Schwartz, P.J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., et al. Risk stratification in the long-QT syndrome. N Engl J Med. 348 (2003), 1866–1874.
9. [9] Behr, E.R., Dalageorgou, C., Christiansen, M., Syrris, P., Hughes, S., Tome Esteban, M.T., et al. Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. Eur Heart J. 29 (2008), 1670–1680.
10. [10] Tan, H.L., Hofman, N., van Langen, I.M., van der Wal, A.C., Wilde, A.A., Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation. 112 (2005), 207–213.
11. [11] Postema, P.G., De Jong, J.S., Van der Bilt, I.A., Wilde, A.A., Accurate electrocardiographic assessment of the QT interval: teach the tangent. Heart Rhythm. 5 (2008), 1015–1018.
12. [12] Monnig, G., Eckardt, L., Wedekind, H., Haverkamp, W., Gerss, J., Milberg, P., et al. Electrocardiographic risk stratification in families with congenital long QT syndrome. Eur Heart J. 27 (2006), 2074–2080.
13. [13] Vincent, G.M., Timothy, K.W., Leppert, M., Keating, M., The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. New England Journal of Medicine. 327 (1992), 846–852.
14. [14] Goldenberg, I., Moss, A.J., Long QT syndrome. J Am Coll Cardiol. 51 (2008), 2291–2300.
15. [15] Priori, S.G., Wilde, A.A., Horie, M., Cho, Y., Behr, E.R., Berul, C., et al. HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes: Document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 10 (2013), 1932–1963.
16. [16] Swan, H., Viitasalo, M., Piippo, K., Laitinen, P., Kontula, K., Toivonen, L., Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. J Am Coll Cardiol. 34 (1999), 823–829.
17. [17] Chattha IS, Sy RW, Yee R, Gula LJ, Skanes AC, Klein GJ, et al. Utility of the recovery electrocardiogram after exercise: a novel indicator for the diagnosis and genotyping of long QT syndrome? Heart Rhythm. 7:906–11.
18. [18] Sy, R.W., van der Werf, C., Chattha, I.S., Chockalingam, P., Adler, A., Healey, J.S., et al. Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands. Circulation. 124 (2011), 2187–2194.
19. [19] Berger, W.R., Gow, R.M., Kamberi, S., Cheung, M., Smith, K.R., Davis, A.M., The QT and corrected QT interval in recovery after exercise in children. Circ Arrhythm Electrophysiol. 4 (2011), 448–455.
20. [20] Viskin, S., Postema, P.G., Bhuiyan, Z.A., Rosso, R., Kalman, J.M., Vohra, J.K., et al. The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. J Am Coll Cardiol. 55 (2010), 1955–1961.
21. [21] Priori, S.G., Schwartz, P.J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., et al. Risk stratification in the long QT syndrome. The New England Journal of Medicine. 348 (2003), 1866–1874.
22. [22] Earle, N., Crawford, J., Smith, W., Hayes, I., Shelling, A., Hood, M., et al. Community detection of long QT syndrome with a clinical registry: an alternative to ECG screening programs?. Heart Rhythm. 10 (2013), 233–238.
23. [23] Altmann, H.M., Tester, D.J., Will, M.L., Middha, S., Evans, J.M., Eckloff, B.W., et al. Homozygous/Compound Heterozygous Triadin Mutations Associated With Autosomal-Recessive Long-QT Syndrome and Pediatric Sudden Cardiac Arrest: Elucidation of the Triadin Knockout Syndrome. Circulation. 131 (2015), 2051–2060.
24. [24] Crotti, L., Johnson, C.N., Graf, E., De Ferrari, G.M., Cuneo, B.F., Ovadia, M., et al. Calmodulin mutations associated with recurrent cardiac arrest in infants. Circulation. 127 (2013), 1009–1017.
25. [25] Schwartz, P.J., Spazzolini, C., Crotti, L., Bathen, J., Amlie, J.P., Timothy, K., et al. The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome. Circulation. 113 (2006), 783–790.
26. [26] Winbo, A., Sandstrom, O., Palmqvist, R., Rydberg, A., Iron-deficiency anaemia, gastric hyperplasia, and elevated gastrin levels due to potassium channel dysfunction in the Jervell and Lange-Nielsen Syndrome. Cardiol Young. 23 (2013), 325–334.
27. [27] Eddy, C.A., MacCormick, J.M., Chung, S.K., Crawford, J.R., Love, D.R., Rees, M.I., et al. Identification of large gene deletions and duplications in KCNQ1 and KCNH2 in patients with long QT syndrome. Heart Rhythm. 5 (2008), 1275–1281.
28. [28] Tester, D.J., Benton, A.J., Train, L., Deal, B., Baudhuin, L.M., Ackerman, M.J., Prevalence and spectrum of large deletions or duplications in the major long QT syndrome-susceptibility genes and implications for long QT syndrome genetic testing. Am J Cardiol. 106 (2010), 1124–1128.
29. [29] Barsheshet A, Goldenberg I, J OU, Moss AJ, Jons C, Shimizu W, et al. Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events: implications for mutation-specific response to beta-blocker therapy in type 1 long-QT syndrome. Circulation. 2012;125:1988–96.
30. [30] Abriel, H., Cardiac sodium channel Na(v)1.5 and interacting proteins: Physiology and pathophysiology. J Mol Cell Cardiol., 2009.
31. [31] Wang, D., Shah, K.R., Um, S.Y., Eng, L.S., Zhou, B., Lin, Y., et al. Cardiac channelopathy testing in 274 ethnically diverse sudden unexplained deaths. Forensic Sci Int. 237 (2014), 90–99.
32. [32] Amin, A.S., Giudicessi, J.R., Tijsen, A.J., Spanjaart, A.M., Reckman, Y.J., Klemens, C.A., et al. Variants in the 3' untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner. Eur Heart J. 33 (2012), 714–723.
33. [33] Earle, N., Yeo Han, D., Pilbrow, A., Crawford, J., Smith, W., Shelling, A.N., et al. Single nucleotide polymorphisms in arrhythmia genes modify the risk of cardiac events and sudden death in long QT syndrome. Heart Rhythm. 11 (2014), 76–82.
34. [34] Ingles, J., Yeates, L., Semsarian, C., The emerging role of the cardiac genetic counselor. Heart Rhythm. 8 (2011), 1958–1962.
35. [35] Tester, D.J., Ackerman, M.J., Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice. Circulation. 123 (2011), 1021–1037.
36. [36] Skinner, J.R., Crawford, J., Smith, W., Aitken, A., Heaven, D., Evans, C.A., et al. Prospective, population-based long QT molecular autopsy study of postmortem negative sudden death in 1 to 40 year olds. Heart Rhythm. 8 (2011), 412–419.
37. [37] Nazeri, A., Massumi, A., Wilson, J.M., Frank, C.M., Bensler, M., Cheng, J., et al. Arrhythmogenicity of weight-loss supplements marketed on the Internet. Heart Rhythm. 6 (2009), 658–662.
38. [38] Sakaguchi, T., Shimizu, W., Itoh, H., Noda, T., Miyamoto, Y., Nagaoka, I., et al. Age- and genotype-specific triggers for life-threatening arrhythmia in the genotyped long QT syndrome. J Cardiovasc Electrophysiol. 19 (2008), 794–799.
39. [39] Johnson, J.N., Ackerman, M.J., Return to play? Athletes with congenital long QT syndrome. Br J Sports Med. 47 (2013), 28–33.
40. [40] Goldenberg, I., Moss, A.J., Peterson, D.R., McNitt, S., Zareba, W., Andrews, M.L., et al. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation. 117 (2008), 2184–2191.
41. [41] Kaufman, E.S., McNitt, S., Moss, A.J., Zareba, W., Robinson, J.L., Hall, W.J., et al. Risk of death in the long QT syndrome when a sibling has died. Heart Rhythm. 5 (2008), 831–836.
42. [42] Goldenberg I, Bradley J, Moss A, McNitt S, Polonsky S, Robinson JL, et al. Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management. J Cardiovasc Electrophysiol. 21:893–901.
43. [43] Vincent, G.M., Schwartz, P.J., Denjoy, I., Swan, H., Bithell, C., Spazzolini, C., et al. High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment “failures”. Circulation. 119 (2009), 215–221.
44. [44] Wilde, A., Kaufman, E.S., Shimizu, W., Moss, A., Benhorin, J., Lopes, C.M., et al. Sodium channel mutations, risk of cardiac events, and efficacy of beta-blocker therapy in type 3 long QT syndrome. Heart Rhythm., 9, 2012, S321.
45. [45] Chockalingam, P., Crotti, L., Girardengo, G., Johnson, J.N., Harris, K.M., van der Heijden, J.F., et al. Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. J Am Coll Cardiol. 60 (2012), 2092–2099.
46. [46] Abu-Zeitone, A., Peterson, D.R., Polonsky, B., McNitt, S., Moss, A.J., Efficacy of different beta-blockers in the treatment of long QT syndrome. J Am Coll Cardiol. 64 (2014), 1352–1358.
47. [47] Horner, J.M., Kinoshita, M., Webster, T.L., Haglund, C.M., Friedman, P.A., Ackerman, M.J., Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience. Heart Rhythm. 7 (2010), 1616–1622.
48. [48] Blaufox, A.D., Tristani-Firouzi, M., Seslar, S., Sanatani, S., Trivedi, B., Fischbach, P., et al. Congenital long QT 3 in the pediatric population. Am J Cardiol. 109 (2012), 1459–1465.
49. [49] Shimizu, W., Kurita, T., Matsuo, K., Suyama, K., Aihara, N., Kamakura, S., et al. Improvement of repolarization abnormalities by a K+ channel opener in the LQT1 form of congenital long-QT syndrome. Circulation. 97 (1998), 1581–1588.
50. [50] Etheridge, S.P., Compton, S.J., Tristani-Firouzi, M., Mason, J.W., A new oral therapy for long QT syndrome: long-term oral potassium improves repolarization in patients with HERG mutations. Journal of the American College of Cardiology. 42 (2003), 1777–1782.
51. [51] Schwartz, P.J., Priori, S.G., Locati, E.H., Napolitano, C., Cantu, F., Towbin, J.A., et al. Long QT Syndrome Patients With Mutations of the SCN5A and HERG Genes Have Differential Responses to Na+ Channel Blockade and to Increases in Heart Rate: Implications for Gene-Specific Therapy. Circulation. 92 (1995), 3381–3386.
52. [52] Beinart, R., Michailidis, A., Gurevitz, O.T., Glikson, M., Is flecainide dangerous in long QT-3 patients?. Pacing Clin Electrophysiol. 32 (2009), 143–145.
53. [53] Jons, C., Moss, A.J., Goldenberg, I., Liu, J., McNitt, S., Zareba, W., et al. Risk of fatal arrhythmic events in long QT syndrome patients after syncope. J Am Coll Cardiol. 55 (2010), 783–788.
54. [54] Zareba, W., Moss, A.J., Daubert, J.P., Hall, W.J., Robinson, J.L., Andrews, M., Implantable cardioverter defibrillator in high-risk long QT syndrome patients. Journal of Cardiovascular Electrophysiology. 14 (2003), 337–341.
55. [55] Olde Nordkamp, L.R., Wilde, A.A., Tijssen, J.G., Knops, R.E., van Dessel, P.F., de Groot, J.R., The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention. Circ Arrhythm Electrophysiol. 6 (2013), 91–100.
56. [56] Schwartz, P.J., Spazzolini, C., Priori, S.G., Crotti, L., Vicentini, A., Landolina, M., et al. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry. Circulation. 122 (2010), 1272–1282.
57. [57] Monnig, G., Kobe, J., Loher, A., Eckardt, L., Wedekind, H., Scheld, H.H., et al. Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: a long-term follow-up. Heart Rhythm. 2 (2005), 497–504.
58. [58] Collura, C.A., Johnson, J.N., Moir, C., Ackerman, M.J., Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery. Heart Rhythm. 6 (2009), 752–759.
59. [59] Schwartz, P.J., Priori, S.G., Cerrone, M., Spazzolini, C., Odero, A., Napolitano, C., et al. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation. 109 (2004), 1826–1833.
60. [60] Waddell-Smith, K.E., Ertresvaag, K.N., Li, J., Chaudhuri, K., Crawford, J.R., Hamill, J.K., et al. Physical and Psychological Consequences of Left Cardiac Sympathetic Denervation in Long-QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia. Circ Arrhythm Electrophysiol. 8 (2015), 1151–1158.
61. [61] Goldenberg, I., Horr, S., Moss, A.J., Lopes, C.M., Barsheshet, A., McNitt, S., et al. Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. J Am Coll Cardiol. 57 (2011), 51–59.
62. [62] Waddell-Smith, K.E., Earle, N., Skinner, J.R., Must every child with long QT syndrome take a beta blocker?. Arch Dis Child. 100 (2015), 279–282.
63. [63] Modell, S.M., Lehmann, M.H., The long QT syndrome family of cardiac ion channelopathies: a HuGE review. Genet Med. 8 (2006), 143–155.
64. [64] Goldenberg, I., Mathew, J., Moss, A.J., McNitt, S., Peterson, D.R., Zareba, W., et al. Corrected QT variability in serial electrocardiograms in long QT syndrome: the importance of the maximum corrected QT for risk stratification. J Am Coll Cardiol. 48 (2006), 1047–1052.
65. [65] Sauer, A.J., Moss, A.J., McNitt, S., Peterson, D.R., Zareba, W., Robinson, J.L., et al. Long QT syndrome in adults. J Am Coll Cardiol. 49 (2007), 329–337.
66. [66] Seth, R., Moss, A.J., McNitt, S., Zareba, W., Andrews, M.L., Qi, M., et al. Long QT syndrome and pregnancy. J Am Coll Cardiol. 49 (2007), 1092–1098.